Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial

YI Hser, AJ Saxon, D Huang, A Hasson, C Thomas… - …, 2014 - Wiley Online Library
Aims To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …
被引用次数：487 相关文章

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

YI Hser, AJ Saxon, D Huang, A Hasson, C Thomas… - 2014 - pubmed.ncbi.nlm.nih.gov
Aims To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …

[引用][C] Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

YI HSER, AJ SAXON, A COHEN… - Addiction …, 2014 - pascal-francis.inist.fr
Treatment retention among patients randomized to buprenorphine/naloxone compared to
methadone in a multi-site trial CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[HTML] nih.gov

[HTML][HTML] Treatment Retention among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in A Multi-site Trial

YI Hser, AJ Saxon, D Huang, A Hasson… - Addiction (Abingdon …, 2014 - ncbi.nlm.nih.gov
Treatment Retention among Patients Randomized to Buprenorphine/Naloxone Compared to
Methadone in A Multi-site Trial - PMC Back to Top Skip to main content NIH NLM Logo Access …

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.

YI Hser, AJ Saxon, D Huang, A Hasson… - Addiction (Abingdon …, 2013 - europepmc.org
Treatment retention among patients randomized to buprenorphine/naloxone compared to
methadone in a multi-site trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Treatment retention on buprenorphine/methadone

YI Hser, AJ Saxon, D Huang, A Hasson, C Thomas… - Addiction, 2014 - escholarship.org
AimsTo examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.

YI Hser, AJ Saxon, D Huang, A Hasson… - …, 2014 - search.ebscohost.com
Aims To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial.

YI Hser, AJ Saxon, D Huang, A Hasson, C Thomas… - Addiction, 2014 - psycnet.apa.org
Aims: To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial

YI Hser, AJ Saxon, D Huang, A Hasson, C Thomas… - Addiction, 2013 - infona.pl
Aims To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …
[PDF] academia.edu

[PDF][PDF] Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

YI Hser, AJ Saxon, D Huang, A Hasson, C Thomas… - Addiction, 2013 - academia.edu
Aims To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …